Jeffrey B. Kindler - Dec 8, 2021 Form 4 Insider Report for PPD, Inc. (PPD)

Role
Director
Signature
/s/ Richard Whitlow, as Attorney-in-Fact
Stock symbol
PPD
Transactions as of
Dec 8, 2021
Transactions value $
-$5,604,383
Form type
4
Date filed
12/8/2021, 03:39 PM
Previous filing
Sep 30, 2021
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PPD Common Stock Disposed to Issuer -$4.73M -99.5K -100% $47.50 0 Dec 8, 2021 Direct F1, F2, F3
transaction PPD Common Stock Disposed to Issuer -$879K -18.5K -100% $47.50 0 Dec 8, 2021 By Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jeffrey B. Kindler is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger").
F2 Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted.
F3 At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration").